Jongseon Jeong Corrects Share Purchase Dates in Amendment, No Financial Impact
Jongseon Jeong, CEO of SyntekaBio, filed an amendment on July 6 correcting the transaction dates in his previous beneficial ownership report from June 25-26 to June 29-30.
This is a mere clerical correction with no change to the 60,000 shares acquired or the resulting 14.61% ownership stake.
[AI Summary]This is an administrative correction with zero impact on shareholder value. The prior signal of insider buying remains unchanged.
KOSDAQ Filing Information
[Correction of Description] Report on Ownership of Specific Securities, etc. by Executives and Major Shareholders